首页> 外文期刊>Medicinski Preglad >Testing applicability of international guidelines in treatment of sepsis
【24h】

Testing applicability of international guidelines in treatment of sepsis

机译:测试国际准则在败血症治疗中的适用性

获取原文
           

摘要

Introduction. The Department of Infectious Diseases adopted new internal clinical protocols for initial adequate antimicrobial therapy of bacterial infections in January, 2013. Protocols were made up on the basis of European (British National Formulary) and the American (Sanford) guidelines for treatment of bacterial infections. The aim of our study was to investigate the efficiency of new clinical protocols based on international guidelines in treatment of bacteria induced sepsis and to compare it with the efficiency of the existing guidelines, which are based on the use of antibiotics according to clinical experience of the doctors. Material and Methods. The study included 109 patients diagnosed with bacteria-induced sepsis, who were treated at the Department of Infectious Diseases in the period from 1 January, 2012 to 31 December, 2013. Data were collected from the medical records. The patients were divided into two groups. The first group included 54 patients diagnosed with sepsis who were treated empirically. The second group consisted of 55 patients treated according to the new internal protocols. The efficiency of treatment in both groups of patients was monitored by laboratory findings (leukocyte count, C-reactive protein, fibrinogen, sedimentation, procalcitonin), and temperatures, measured on the first and seventh day of hospitalization. For statistical analysis, we used the χ2 test. Results. After the applied treatment, there was a statistically significant decrease in the mean values of C-reactive protein P and procalcitonin on the seventh day of treatment in both groups of patients. The most frequently applied therapy was triple antibiotic therapy - ceftriaxone, ciprofloxacin and metronidazole, in both groups. Conclusion. Treatment of bacteria-induced sepsis according to internationally accepted protocols for treatment of bacterial infections is as effective as treatment of sepsis according to the clinical experience of doctors.
机译:介绍。传染病部于2013年1月采用了新的内部临床方案,对细菌感染进行了初步的适当抗菌治疗。该方案是根据欧洲(英国国家配方)和美国(桑福德)的细菌感染治疗指南制定的。我们研究的目的是研究基于国际指南治疗细菌性败血症的新临床方案的效率,并将其与现有指南的效率进行比较,现有指南的有效性基于抗生素的败血症的临床经验。医生。材料与方法。该研究纳入了109名被诊断为细菌性败血症的患者,这些患者在2012年1月1日至2013年12月31日期间在传染病科接受了治疗。数据来自医疗记录。将患者分为两组。第一组包括54例经确诊为败血症的患者,均接受了经验治疗。第二组包括根据新的内部规程治疗的55名患者。两组患者的治疗效率通过实验室检查(白细胞计数,C反应蛋白,纤维蛋白原,沉积,降钙素原)和温度在住院的第一天和第七天进行监测。为了进行统计分析,我们使用χ2检验。结果。应用治疗后,两组患者在治疗的第7天,C反应蛋白P和降钙素的平均值均在统计学上显着下降。两组中最常用的疗法是三联抗生素疗法-头孢曲松,环丙沙星和甲硝唑。结论。根据医生的临床经验,根据国际公认的治疗细菌感染的方案来治疗细菌性脓毒症与治疗脓毒症一样有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号